These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33710299)

  • 1. GABAergic cortical network physiology in frontotemporal lobar degeneration.
    Adams NE; Hughes LE; Rouse MA; Phillips HN; Shaw AD; Murley AG; Cope TE; Bevan-Jones WR; Passamonti L; Street D; Holland N; Nesbitt D; Friston K; Rowe JB
    Brain; 2021 Aug; 144(7):2135-2145. PubMed ID: 33710299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA-ergic Dynamics in Human Frontotemporal Networks Confirmed by Pharmaco-Magnetoencephalography.
    Adams NE; Hughes LE; Phillips HN; Shaw AD; Murley AG; Nesbitt D; Cope TE; Bevan-Jones WR; Passamonti L; Rowe JB
    J Neurosci; 2020 Feb; 40(8):1640-1649. PubMed ID: 31915255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurophysiological effect of NMDA-R antagonism of frontotemporal lobar degeneration is conditional on individual GABA concentration.
    Perry A; Hughes LE; Adams N; Naessens M; Murley AG; Rouse MA; Street D; Jones PS; Cope TE; Kocagoncu E; Rowe JB
    Transl Psychiatry; 2022 Aug; 12(1):348. PubMed ID: 36030249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition.
    Murley AG; Rouse MA; Jones PS; Ye R; Hezemans FH; O'Callaghan C; Frangou P; Kourtzi Z; Rua C; Carpenter TA; Rodgers CT; Rowe JB
    Brain; 2020 Dec; 143(11):3449-3462. PubMed ID: 33141154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apathy and impulsivity in frontotemporal lobar degeneration syndromes.
    Lansdall CJ; Coyle-Gilchrist ITS; Jones PS; Vázquez Rodríguez P; Wilcox A; Wehmann E; Dick KM; Robbins TW; Rowe JB
    Brain; 2017 Jun; 140(6):1792-1807. PubMed ID: 28486594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving response inhibition systems in frontotemporal dementia with citalopram.
    Hughes LE; Rittman T; Regenthal R; Robbins TW; Rowe JB
    Brain; 2015 Jul; 138(Pt 7):1961-75. PubMed ID: 26001387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes.
    Murley AG; Coyle-Gilchrist I; Rouse MA; Jones PS; Li W; Wiggins J; Lansdall C; Rodríguez PV; Wilcox A; Tsvetanov KA; Patterson K; Lambon Ralph MA; Rowe JB
    Brain; 2020 May; 143(5):1555-1571. PubMed ID: 32438414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The applause sign in frontotemporal lobar degeneration and related conditions.
    Schönecker S; Hell F; Bötzel K; Wlasich E; Ackl N; Süßmair C; ; Otto M; Anderl-Straub S; Ludolph A; Kassubek J; Huppertz HJ; Diehl-Schmid J; Riedl L; Roßmeier C; Fassbender K; Lyros E; Kornhuber J; Oberstein TJ; Fliessbach K; Schneider A; Schroeter ML; Prudlo J; Lauer M; Jahn H; Levin J; Danek A
    J Neurol; 2019 Feb; 266(2):330-338. PubMed ID: 30506397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype.
    Sami S; Williams N; Hughes LE; Cope TE; Rittman T; Coyle-Gilchrist ITS; Henson RN; Rowe JB
    Brain; 2018 Aug; 141(8):2500-2510. PubMed ID: 30060017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reorganization of cortical oscillatory dynamics underlying disinhibition in frontotemporal dementia.
    Hughes LE; Rittman T; Robbins TW; Rowe JB
    Brain; 2018 Aug; 141(8):2486-2499. PubMed ID: 29992242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causal Evidence for the Multiple Demand Network in Change Detection: Auditory Mismatch Magnetoencephalography across Focal Neurodegenerative Diseases.
    Cope TE; Hughes LE; Phillips HN; Adams NE; Jafarian A; Nesbitt D; Assem M; Woolgar A; Duncan J; Rowe JB
    J Neurosci; 2022 Apr; 42(15):3197-3215. PubMed ID: 35260433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurophysiological consequences of synapse loss in progressive supranuclear palsy.
    Adams NE; Jafarian A; Perry A; Rouse MA; Shaw AD; Murley AG; Cope TE; Bevan-Jones WR; Passamonti L; Street D; Holland N; Nesbitt D; Hughes LE; Friston KJ; Rowe JB
    Brain; 2023 Jun; 146(6):2584-2594. PubMed ID: 36514918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontotemporal lobar degeneration changes neuronal beta-frequency dynamics during the mismatch negativity response.
    Perry A; Hughes LE; Adams NE; Naessens M; Kloosterman NA; Rouse MA; Murley AG; Street D; Jones PS; Rowe JB
    Neuroimage Clin; 2024; 44():103671. PubMed ID: 39305652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetoencephalography of frontotemporal dementia: spatiotemporally localized changes during semantic decisions.
    Hughes LE; Nestor PJ; Hodges JR; Rowe JB
    Brain; 2011 Sep; 134(Pt 9):2513-22. PubMed ID: 21840892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished preparatory physiological responses in frontotemporal lobar degeneration syndromes.
    Chen KH; Hua AY; Toller G; Lwi SJ; Otero MC; Haase CM; Rankin KP; Rosen HJ; Miller BL; Levenson RW
    Brain Commun; 2022; 4(2):fcac075. PubMed ID: 35441132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuropsychological profile of frontotemporal lobar degeneration].
    Carmona-Abellán MM; Luquin MR; Lamet I; Pujol Giménez N; Esteve-Belloch P; Rivero M
    An Sist Sanit Navar; 2015; 38(1):79-92. PubMed ID: 25963461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.
    Hirano S; Shinotoh H; Shimada H; Aotsuka A; Tanaka N; Ota T; Sato K; Ito H; Kuwabara S; Fukushi K; Irie T; Suhara T
    Brain; 2010 Jul; 133(Pt 7):2058-68. PubMed ID: 20558417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton magnetic resonance spectroscopy in frontotemporal lobar degeneration-related syndromes.
    Murley AG; Tsvetanov KA; Rouse MA; Jones PS; Sværke K; Li W; Carpenter A; Rowe JB
    Neurobiol Aging; 2022 Mar; 111():64-70. PubMed ID: 34971846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic changes associated with frontotemporal lobar degeneration syndromes.
    Murley AG; Jones PS; Coyle Gilchrist I; Bowns L; Wiggins J; Tsvetanov KA; Rowe JB
    J Neurol; 2020 Aug; 267(8):2228-2238. PubMed ID: 32277260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Odor identification in frontotemporal lobar degeneration subtypes.
    Magerova H; Vyhnalek M; Laczo J; Andel R; Rektorova I; Kadlecova A; Bojar M; Hort J
    Am J Alzheimers Dis Other Demen; 2014 Dec; 29(8):762-8. PubMed ID: 24939002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.